Nakazawa, N.; Yokobori, T.; Sohda, M.; Hosoi, N.; Watanabe, T.; Shimoda, Y.; Ide, M.; Sano, A.; Sakai, M.; Erkhem-Ochir, B.;
et al. Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity. Int. J. Mol. Sci. 2023, 24, 11790.
https://doi.org/10.3390/ijms241411790
AMA Style
Nakazawa N, Yokobori T, Sohda M, Hosoi N, Watanabe T, Shimoda Y, Ide M, Sano A, Sakai M, Erkhem-Ochir B,
et al. Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity. International Journal of Molecular Sciences. 2023; 24(14):11790.
https://doi.org/10.3390/ijms241411790
Chicago/Turabian Style
Nakazawa, Nobuhiro, Takehiko Yokobori, Makoto Sohda, Nobuhiro Hosoi, Takayoshi Watanabe, Yuki Shimoda, Munenori Ide, Akihiko Sano, Makoto Sakai, Bilguun Erkhem-Ochir,
and et al. 2023. "Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity" International Journal of Molecular Sciences 24, no. 14: 11790.
https://doi.org/10.3390/ijms241411790
APA Style
Nakazawa, N., Yokobori, T., Sohda, M., Hosoi, N., Watanabe, T., Shimoda, Y., Ide, M., Sano, A., Sakai, M., Erkhem-Ochir, B., Ogawa, H., Shirabe, K., & Saeki, H.
(2023). Significance of Lipopolysaccharides in Gastric Cancer and Their Potential as a Biomarker for Nivolumab Sensitivity. International Journal of Molecular Sciences, 24(14), 11790.
https://doi.org/10.3390/ijms241411790
